Sequential data mining of infection patterns as predictors for onset of type 1 diabetes in genetically at-risk individuals.

Disease Etiology Infections Risk Assessment Sequential Data Mining The Environmental Determinants of Diabetes in the Young Study Type 1 Diabetes Mellitus

Journal

Journal of biomedical informatics
ISSN: 1532-0480
Titre abrégé: J Biomed Inform
Pays: United States
ID NLM: 100970413

Informations de publication

Date de publication:
06 2023
Historique:
received: 14 02 2023
revised: 02 05 2023
accepted: 04 05 2023
pmc-release: 01 06 2024
medline: 5 6 2023
pubmed: 12 5 2023
entrez: 11 5 2023
Statut: ppublish

Résumé

Infections are implicated in the etiology of type 1 diabetes mellitus (T1DM); however, conflicting epidemiologic evidence makes designing effective strategies for presymptomatic screening and disease prevention difficult. Considering the temporality and combination in which infections occur may provide valuable insights into understanding T1DM etiology but is rarely studied due to limited longitudinal datasets and insufficient analytical techniques. The objective of this work was to demonstrate a computational approach to classify the temporality and combination of infections in presymptomatic T1DM. We present a sequential data mining pipeline that leverages routinely collected infectious disease data from a prospective cohort study, the Environmental Determinants of Diabetes in the Young (TEDDY) study, to extract, interpret, and compare infection sequences. We then utilize this pipeline to assess risk for developing presymptomatic biomarkers of islet autoimmunity and clinical onset of T1DM. Overall, we identified 229 significant sequential rules that increased the risk for developing presymptomatic biomarkers of islet autoimmunity or clinical onset of T1DM. Multiple significant sequential rules involving varicella increased the risk for all presymptomatic biomarker-specific outcomes, while a single significant sequential rule involving parasites significantly increased risk for T1DM. Significant sequential rules involving respiratory illnesses were differentially represented among the presymptomatic biomarkers of islet autoimmunity and clinical onset of T1DM. Risk for T1DM was significantly increased by a single episode of sixth disease at 12 months, representing the only single-event sequence that increased disease risk. Together, these findings provide the first insights into the timing and combination of infections in T1DM etiology, which may ultimately lead to personalized disease screening and prevention strategies. The sequential data mining pipeline developed in this work demonstrates how temporal data mining can be used to address clinically meaningful questions. This method can be adapted to other presymptomatic factors and clinical conditions.

Identifiants

pubmed: 37169058
pii: S1532-0464(23)00106-5
doi: 10.1016/j.jbi.2023.104385
pmc: PMC10247497
mid: NIHMS1902610
pii:
doi:

Substances chimiques

Autoantibodies 0
Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

104385

Subventions

Organisme : NIDDK NIH HHS
ID : F30 DK134113
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States
Organisme : NCATS NIH HHS
ID : UM1 TR004409
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Appl Intell (Dordr). 2022;52(14):16458-16474
pubmed: 35340983
Trends Immunol. 2009 Aug;30(8):409-14
pubmed: 19643667
Br Med J. 1973 Jul 7;3(5870):25-7
pubmed: 4577716
Eur J Epidemiol. 2003;18(5):425-30
pubmed: 12889689
Diabetes Care. 2023 Feb 1;46(2):313-320
pubmed: 36580405
Diabetes. 2004 Feb;53(2):384-92
pubmed: 14747289
Diabetologia. 2023 Mar;66(3):520-534
pubmed: 36446887
JAMIA Open. 2021 Jul 15;4(3):ooab063
pubmed: 34409266
Clin Exp Immunol. 2002 Jun;128(3):511-5
pubmed: 12067306
Diabetes. 2020 Jul;69(7):1311-1335
pubmed: 32561620
Ann N Y Acad Sci. 2002 Apr;958:163-5
pubmed: 12021098
Diabetes Care. 2023 Jan 1;46(Suppl 1):S49-S67
pubmed: 36507651
Diabetes Care. 2015 Oct;38(10):1964-74
pubmed: 26404926
JAMA. 2013 Jun 19;309(23):2473-9
pubmed: 23780460
Pediatr Diabetes. 2011 Dec;12(8):733-43
pubmed: 21564455
Ann N Y Acad Sci. 2008 Dec;1150:1-13
pubmed: 19120261
Pediatr Diabetes. 2007 Oct;8(5):286-98
pubmed: 17850472
JAMA. 2016 May 3;315(17):1899-901
pubmed: 27139064
J Clin Invest. 2001 Oct;108(8):1097-104
pubmed: 11602615
Diabetes Care. 1997 Jul;20(7):1183-97
pubmed: 9203460
BMC Pediatr. 2015 Mar 20;15:24
pubmed: 25884839
J Clin Endocrinol Metab. 2010 Jul;95(7):3360-7
pubmed: 20444913
Diabetes Care. 2018 May;41(5):963-970
pubmed: 29475843
BMJ. 2011 Feb 03;342:d35
pubmed: 21292721
Lancet. 2016 Jun 4;387(10035):2340-2348
pubmed: 27302273
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1783-1789
pubmed: 32947109
Lancet. 1988 Jul 2;2(8601):1-4
pubmed: 2898620
Clin Exp Immunol. 2010 Apr;160(1):1-9
pubmed: 20415844
Diabetes Metab Res Rev. 2014 Jul;30(5):424-34
pubmed: 24339168
Diabetes. 2000 Aug;49(8):1314-8
pubmed: 10923631
J Med Virol. 2002 Mar;66(3):340-50
pubmed: 11793386
Diabetologia. 2008 May;51(5):769-72
pubmed: 18278478
J Clin Invest. 1994 Nov;94(5):2125-9
pubmed: 7962558
MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):59-65
pubmed: 35025851
Mol Med. 1998 Apr;4(4):231-9
pubmed: 9606176
Diabetes. 2000 Aug;49(8):1319-24
pubmed: 10923632
Diabetes Care. 2018 May;41(5):917-928
pubmed: 29567642
Diabetologia. 2022 Dec;65(12):2098-2107
pubmed: 36083343
JAMA. 2022 Sep 27;328(12):1252-1255
pubmed: 35930271
Diabetologia. 2017 Oct;60(10):1931-1940
pubmed: 28770319
Adv Databases Inf Syst. 2021 Aug;1450:50-60
pubmed: 34604867
Pediatr Diabetes. 2022 Nov;23(7):926-943
pubmed: 35821595
J Autoimmun. 2020 Feb;107:102378
pubmed: 31818546
Transpl Int. 2010 Mar 1;23(3):333-7
pubmed: 19906032
Rev Diabet Stud. 2012 Winter;9(4):272-86
pubmed: 23804266

Auteurs

Sejal Mistry (S)

Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, USA; Center of Excellence for Exposure Health Informatics, University of Utah, Salt Lake City, UT, USA.

Ramkiran Gouripeddi (R)

Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, USA; Center of Excellence for Exposure Health Informatics, University of Utah, Salt Lake City, UT, USA; Clinical and Translational Science Institute, University of Utah, Salt Lake City, UT, USA.

Vandana Raman (V)

Division of Pediatric Endocrinology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.

Julio C Facelli (JC)

Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, USA; Center of Excellence for Exposure Health Informatics, University of Utah, Salt Lake City, UT, USA; Clinical and Translational Science Institute, University of Utah, Salt Lake City, UT, USA. Electronic address: julio.facelli@utah.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH